Blog

The field of clinical research is the bedrock upon which modern medicine builds its advancements. The importance of addressing challenges and seizing opportunities in this domain cannot be overstated. As the healthcare and life sciences industry continues to evolve, an understanding of the impact of effective clinical research is vital to medical innovations and patient […]

Clinical research is an ever-evolving field, constantly seeking new ways to innovate and adapt. One significant trend driving this change is the rise of Artificial Intelligence (AI). In recent years, AI is revolutionising core aspects of research, supporting data-driven predictions, crucial for designing optimal clinical trials.  By leveraging causal AI models, researchers can enhance their […]

Developing new and innovative treatments for disorders affecting the central nervous system is a long-standing issue in the landscape of CNS drug development. The complexity in the function of the brain and the spinal cord means development and trial success of new and effective CNS drugs is a long and often unsuccessful process.  Historically, failure […]

Are you considering conducting a clinical trial in the UK but have concerns about additional complexities of IMP importation? As an authorised importer of Investigational Medicinal Products, Simbec-Orion works with biotech and pharmaceutical clients to conduct clinical research internationally and have an experienced and knowledgeable regulatory team to ensure seamless IMP importation for your clinical […]

Our last blog post looked at what is required for a clinical trial unit to achieve an MHRA accreditation, including a commitment to the highest safety standards, comprehensive procedures and processes, and capable, experienced teams. The benefits of an MHRA Phase I accredited site, inspected and approved by regulators, remain the same for a patient […]

What is a MHRA Phase I accreditation?If you are considering placing your phase I study in the UK, you may have come across CROs or Phase I Units with an MHRA Phase I accreditation – but what does this mean? The MHRA’s voluntary phase I accreditation scheme is available to organisations conducting phase I trials […]

One year after the UK’s biggest overhaul of clinical trial regulation in 20 years, is the UK on its way to becoming a first-class choice for commercial clinical research? Legislative changes to streamline clinical trial approvals were announced by the MHRA in March 2023, promising the biggest overhaul of UK regulation in 20 years to […]